Direct‐to‐Consumer Genetic Testing

作者: Louiza Kalokairinou , Heidi C Howard , Pascal Borry

DOI: 10.1002/9780470015902.A0025181

关键词:

摘要: Currently, a wide variety of genetic tests are offered direct-to-consumer (DTC), often without involving healthcare professional. The potential benefits and harms such have caused controversy; proponents stress the right to information consumer empowerment, while concerns include questionable scientific quality utility harmful health decisions taken in absence medical supervision counselling. Studies indicate that despite relatively low public awareness regarding services, consumers value their motivation for buying ranges from acquiring health-related satisfying curiosity. Furthermore, professionals seem be sceptical this provision model some tests. ongoing revision European legislation regarding, among others, testing, recent regulatory action against testing company US DTC landscape may change significantly future. Key Concepts: Over last decade, commercial companies been offering non-health-related involvement providers. Various aspects numerous professionals, policy makers consumers, however, has also gained supporters. Consumers’ motivations using services vary widely. Healthcare providers seem, degree, testing. The Food Drug Administration recently adopted stricter position regulation by requiring 23andMe provide evidence safety efficacy its personal genome service. The EU Directive on vitro diagnostic devices is expected have, an important impact landscape. Keywords: direct-to-consumer; genetic testing; medical supervision; genetic counselling; regulation; consumers' awareness; healthcare professionals' attitudes

参考文章(40)
J. Savard, J. Mooney-Somers, A. J. Newson, I. Kerridge, Australians' knowledge and perceptions of direct-to-consumer personal genome testing. Internal Medicine Journal. ,vol. 44, pp. 27- 31 ,(2014) , 10.1111/IMJ.12289
Cynthia Marietta, Amy L. McGuire, Currents in contemporary ethics. Direct-to-consumer genetic testing: is it the practice of medicine? Journal of Law Medicine & Ethics. ,vol. 37, pp. 369- 374 ,(2009) , 10.1111/J.1748-720X.2009.00380.X
Amy L. McGuire, Christina M. Diaz, Tao Wang, Susan G. Hilsenbeck, Social Networkers’ Attitudes Toward Direct-to-Consumer Personal Genome Testing American Journal of Bioethics. ,vol. 9, pp. 3- 10 ,(2009) , 10.1080/15265160902928209
Pascal Borry, Heidi C. Howard, Karine Sénécal, Denise Avard, Direct-to-consumer genome scanning services. Also for children? Nature Reviews Genetics. ,vol. 10, pp. 8- 8 ,(2009) , 10.1038/NRG2501
Yeyang Su, Heidi C. Howard, Pascal Borry, Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. Journal of Community Genetics. ,vol. 2, pp. 135- 146 ,(2011) , 10.1007/S12687-011-0048-Y
Patricia J. Zettler, Jacob S. Sherkow, Henry T. Greely, 23andMe, the Food and Drug Administration, and the Future of Genetic Testing JAMA Internal Medicine. ,vol. 174, pp. 493- 494 ,(2014) , 10.1001/JAMAINTERNMED.2013.14706
George J. Annas, Sherman Elias, 23andMe and the FDA New England Journal of Medicine. ,vol. 370, pp. 985- 988 ,(2014) , 10.1056/NEJMP1316367
E. Vayena, E. Gourna, J. Streuli, E. Hafen, B. Prainsack, Experiences of Early Users of Direct-to-Consumer Genomics in Switzerland: An Exploratory Study Public Health Genomics. ,vol. 15, pp. 352- 362 ,(2012) , 10.1159/000343792
Bryn Williams-Jones, Where there's a web, there's a way: commercial genetic testing and the Internet. Public Health Genomics. ,vol. 6, pp. 46- 57 ,(2003) , 10.1159/000069538